Latest News and Press Releases

MONROE TOWNSHIP, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine...

HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced the consideration payable in respect of its offers to purchase for cash (collectively, the “Tender Offers” and each...

Fourth Quarter Sales of $65.4 million, Adjusted EBITDA of $1.2 million, and Free Cash Flow of $11.6 million Continued Focus on Simplification Strategy to Position Company for Profitable Growth ...

Net Sales Growth of ~2% Year-Over-YearHealthy Balance Sheet and Strong LiquidityWell Positioned to Capitalize on Pent-Up Demand HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in...

WEST ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Bel Fuse Inc.® (Nasdaq: BELFA and BELFB) (“Bel” or “the Company”), a leading global manufacturer of products that power, protect and connect...

Strongest Quarterly and Annual Results in Company History Q4 GAAP Net Combined Ratio of 64.2% | Q4 Diluted EPS of $1.03 | Q4 Annualized ROE of 51.3%Q4 Diluted Operating EPS1 of $1.08 | FY Net Income...

– Approximately 82% of Annual Base Rent from Industrial Properties –– Acquires 23 Industrial Properties for $245.5 Million in 2025 and Subsequent to Year End –– Completes Sale of 12 Non-Core Assets...

Natural Resource Partners L.P. 2025 Tax Information

ISELIN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...